Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Smith

Showing results (251-260 of 618) with videos related to

Pageof 62
Sort By:
Neurotoxicity Research|January 13, 2004
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer diseaseGjumrakch Aliev, Mark A Smith, Mark E Obrenovich, et al.
Chemical Research in Toxicology|August 16, 2005
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenalDe Lin, Hyoung-gon Lee, Quan Liu, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer diseasePaula I Moreira, Lawrence M Sayre, Xiongwei Zhu, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|October 11, 2002
Is Alzheimer's disease a mitochondrial disorder?Adam D Cash, George Perry, Osamu Ogawa, et al.
Nature Neuroscience|September 14, 2004
Rolling blackout, a newly identified PIP2-DAG pathway lipase required for Drosophila phototransductionFu-De Huang, Heinrich J G Matthies, Sean D Speese, et al.
Molecular and Cellular Biochemistry|September 24, 2005
Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymersIsmael Santa-María, Félix Hernández, Mark A Smith, et al.
Neuroscience Bulletin|April 16, 2014
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glassDavid J Bonda, Xinglong Wang, Hyoung-Gon Lee, et al.
Drug and Alcohol Dependence|July 31, 2025
Mu-opioid mediated discriminative stimulus effects of fentanyl and xylazine: Dose-response and time-course studiesMark A Smith, Anthony G Spera, Emma M Thomas, et al.
Ageing Research Reviews|January 26, 2011
Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Sónia C Correia, Renato X Santos, George Perry, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2010
Mitochondrial Drugs for Alzheimer DiseaseDavid J Bonda, Xinglong Wang, Katarzyna A Gustaw-Rothenberg, et al.
Pageof 62

Showing results (251-260 of 618) with videos related to

Sort By:
Pageof 62
Neurotoxicity Research|January 13, 2004
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer diseaseGjumrakch Aliev, Mark A Smith, Mark E Obrenovich, et al.
Chemical Research in Toxicology|August 16, 2005
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenalDe Lin, Hyoung-gon Lee, Quan Liu, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer diseasePaula I Moreira, Lawrence M Sayre, Xiongwei Zhu, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|October 11, 2002
Is Alzheimer's disease a mitochondrial disorder?Adam D Cash, George Perry, Osamu Ogawa, et al.
Nature Neuroscience|September 14, 2004
Rolling blackout, a newly identified PIP2-DAG pathway lipase required for Drosophila phototransductionFu-De Huang, Heinrich J G Matthies, Sean D Speese, et al.
Molecular and Cellular Biochemistry|September 24, 2005
Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymersIsmael Santa-María, Félix Hernández, Mark A Smith, et al.
Neuroscience Bulletin|April 16, 2014
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glassDavid J Bonda, Xinglong Wang, Hyoung-Gon Lee, et al.
Drug and Alcohol Dependence|July 31, 2025
Mu-opioid mediated discriminative stimulus effects of fentanyl and xylazine: Dose-response and time-course studiesMark A Smith, Anthony G Spera, Emma M Thomas, et al.
Ageing Research Reviews|January 26, 2011
Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Sónia C Correia, Renato X Santos, George Perry, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2010
Mitochondrial Drugs for Alzheimer DiseaseDavid J Bonda, Xinglong Wang, Katarzyna A Gustaw-Rothenberg, et al.
Pageof 62